• Revolo and Northway Biotech Enter Manufacturing Partnership contractpharma
    June 15, 2021
    ​Revolo Biotherapeutics has entered into a partnership with Northway Biotech, a global end-to-end biopharmaceutical contract development and manufacturing organization (CDMO), to manufacture its binding immuno-regulatory protein, ‘1805.
PharmaSources Customer Service